Corpus Striatum
This graph shows the total number of publications written about "Corpus Striatum" by people in the URMC Research Network by year, and whether "Corpus Striatum" was a major or minor topic of these publication.
Below are the most recent publications written about "Corpus Striatum" by people in Profiles.
-
Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M, Hwang DR, Huang Y, Haber SN, Laruelle M. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry. 2010 Mar; 67(3):231-9.
-
Biglan KM, Ross CA, Langbehn DR, Aylward EH, Stout JC, Queller S, Carlozzi NE, Duff K, Beglinger LJ, Paulsen JS. Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study. Mov Disord. 2009 Sep 15; 24(12):1763-72.
-
Cory-Slechta DA, Virgolini MB, Rossi-George A, Weston D, Thiruchelvam M. Experimental manipulations blunt time-induced changes in brain monoamine levels and completely reverse stress, but not Pb+/-stress-related modifications to these trajectories. Behav Brain Res. 2009 Dec 14; 205(1):76-87.
-
Cui M, Aras R, Christian WV, Rappold PM, Hatwar M, Panza J, Jackson-Lewis V, Javitch JA, Ballatori N, Przedborski S, Tieu K. The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci U S A. 2009 May 12; 106(19):8043-8.
-
Ernst M, Fudge JL. A developmental neurobiological model of motivated behavior: anatomy, connectivity and ontogeny of the triadic nodes. Neurosci Biobehav Rev. 2009 Mar; 33(3):367-82.
-
Haber SN, McGinty JF, Mugnaini E, Zaborszky L. Lennart Heimer: in memoriam (1930--2007). Brain Struct Funct. 2008 Sep; 213(1-2):3-10.
-
Kong PJ, Kil MO, Lee H, Kim SS, Johnson GV, Chun W. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line. Neurol Res. 2009 Feb; 31(1):77-83.
-
Quintanilla RA, Jin YN, Fuenzalida K, Bronfman M, Johnson GV. Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease. J Biol Chem. 2008 Sep 12; 283(37):25628-37.
-
Stopczynski RE, Poloskey SL, Haber SN. Cell proliferation in the striatum during postnatal development: preferential distribution in subregions of the ventral striatum. Brain Struct Funct. 2008 Sep; 213(1-2):119-27.
-
Paletzki RF, Myakishev MV, Polesskaya O, Orosz A, Hyman SE, Vinson C. Inhibiting activator protein-1 activity alters cocaine-induced gene expression and potentiates sensitization. Neuroscience. 2008 Apr 9; 152(4):1040-53.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
